Adma Biologics, INC.
Biopharmaceutical company
Based in FL
🤖
AI Overview
With $120K in lobbying spend across 24 quarterly filings, Adma Biologics, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2025.
$120K
Total Spend
6
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $30K |
| 2022 | $40K |
| 2023 | $30K |
| 2024 | $10K |
| 2025 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Defense
- •Issues related to the treatment of immune compromised patients who have documented COVID-19 infections.
- •Meetings with officials relating to plasma.
- •National Defense Authorization Act for FY22, provisions relating to plasma-derived antibody products.
- •Department of Defense Appropriations Act for FY22, provisions relating to plasma-derived antibody
- •Labor, Health and Human Services, Education and Related Agencies Appropriations Bill for FY22, provisions relating to plasma-derived antibody products.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.